Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center.

Background: Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and has potential for regional or distant metastasis. Despite the standardization of features associated with high-risk cSCC, an advanced subset of cSCC, there is no established consensus regarding proper management of this tumor.

Objective: To evaluate the efficacy of cetuximab, add to existing management options, and aid in the development of standardized treatment for this tumor.

Hypothyroidism Potentially Linked to Cutaneous Squamous Cell Carcinoma: Retrospective Study at a Single Tertiary Academic Medical Center.

Background: There are multiple known risk factors for the development of cutaneous squamous cell carcinoma (SCC).

Objective: To determine whether patients with cutaneous SCC have a higher prevalence of hypothyroidism than the general US population.

Materials And Methods: A retrospective review was performed for patients seen at the University of Southern California with cutaneous SCC.

Cisplatin and Cetuximab Treatment for Metastatic Cutaneous Squamous Cell Carcinoma: A Systematic Review.

Background: Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and metastasizes in 2% to 5% of cases.

Objective: Systematic evaluation of published cases of metastatic cSCC (mSCC) treated with cisplatin or cetuximab from 1989 to 2014.

Materials And Methods: A literature search was performed to identify cases of mSCC treated with cisplatin or cetuximab.